Talis Biomedical Corp (33) | Uncategorized (12)

Recent Contracts

Offer Letter, dated December 8, 2021, by and between the Company and Robert Kelley (Filed With SEC on December 9, 2021)
Talis Biomedical Corporation 2021 Inducement Plan (Filed With SEC on November 15, 2021)
Offer Letter, dated November 1, 2021, by and between the Company and Brian Blaser (Filed With SEC on November 15, 2021)
Description of Securities (Filed With SEC on March 30, 2021)
Nominating Agreement, dated November 1, 2019, by and among the Registrant, Baker Brothers Life Sciences, L.P. and 667, L.P (Filed With SEC on January 22, 2021)
Form of Indemnity Agreement, by and between the Registrant and its directors and officers (Filed With SEC on January 22, 2021)
Offer Letter, dated April 3, 2020, by and between the Registrant and J. Roger Moody, Jr (Filed With SEC on January 22, 2021)
Offer Letter, dated December 1, 2014, by and between the Registrant and Karen E. Flick (Filed With SEC on January 22, 2021)
Offer Letter, dated August 19, 2020, by and between the Registrant and Robert Kelley (Filed With SEC on January 22, 2021)
Offer Letter, dated September 21, 2020, by and between the Registrant and Douglas Liu (Filed With SEC on January 22, 2021)
Offer Letter, dated April 23, 2019, by and between the Registrant and Ramesh Ramakrishnan (Filed With SEC on January 22, 2021)
Contract, dated July 30, 2020, by and between the Registrant and the National Institutes of Health (Filed With SEC on January 22, 2021)